|
|
Volumn 3, Issue 3, 2001, Pages 223-227
|
|
STI571: a gene product-targeted therapy for leukemia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
ENZYME INHIBITOR;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
CHRONIC MYELOID LEUKEMIA;
DRUG ANTAGONISM;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETICS;
HUMAN;
REVIEW;
ANTINEOPLASTIC AGENTS;
ENZYME INHIBITORS;
FUSION PROTEINS, BCR-ABL;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE THERAPY;
HUMANS;
LEUKEMIA, MYELOID, CHRONIC;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
|
|
EID: 0035344667
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-001-0054-z Document Type: Review |
|
Times cited : (35)
|
|
References (38)
|
